跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 淑娟
教授
,
藥物科學學科
合聘教授
,
中草藥臨床藥物研發博士學位學程
https://orcid.org/0000-0002-6961-4890
電子郵件
shwu-lin
tmu.edu
tw
h-index
881
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1996 …
2025
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(47)
資料集
(18)
類似的個人檔案
(6)
指紋
查看啟用 Shwu-Jiuan Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Aspergillus Niger
100%
Dexamethasone
87%
Steviol
86%
Malignant Neoplasm
75%
Pharmacokinetics
73%
Hepatitis B Virus
72%
Levodopa
64%
Lactone
64%
Bioavailability
56%
Breast Cancer
54%
Cunninghamella
50%
Umbelopsis isabellina
50%
Cytotoxicity
48%
Anticarcinogen
47%
Leporidae
43%
COX-2 Inhibitor
43%
Caffeic Acid
43%
Androgen
43%
Epoxide
43%
Lactam
43%
Lignan
43%
Luciferase
42%
Neoplasm
42%
Glucocorticoid
40%
Biological Activity
38%
Nuclear Factor
38%
Alternative Complement Pathway C3 C5 Convertase
38%
Absidia
37%
Glycoside
36%
Lipopolysaccharide
36%
Antidiabetic Agent
35%
Bacillus Megaterium
33%
Methylprednisolone
33%
Alkadiene
32%
Cyclooxygenase 2
31%
Mouse
30%
Benzenesulfonamide Derivative
28%
Streptomyces Griseus
28%
Antivirus Agent
27%
Virus DNA
26%
Transcription Factor AP 1
26%
Adverse Event
25%
Ferulic Acid
25%
Mucor
25%
Stilbene
24%
High Performance Liquid Chromatography
24%
Integrin
21%
Lactuca
21%
Ovary Cancer
21%
Pancreas Cancer
21%
Biochemistry, Genetics and Molecular Biology
Metabolite
92%
Hepatitis B Virus
54%
Biotransformation
50%
Gene Expression
33%
Pharmacokinetics
30%
Liquid Chromatography-Mass Spectrometry
28%
Cunninghamella
27%
Complement Factor B
26%
Biological Activity
25%
Streptomyces Griseus
24%
Glucose Blood Level
23%
PD-L1
21%
Hyperglycemia
21%
Umbelopsis isabellina
21%
Binding Protein
21%
Small Molecule
21%
Cancer Survival
21%
Tandem Mass Spectrometry
21%
Lipid
21%
Observational Study
21%
Comorbidity
21%
Hyperlipidemia
21%
Random Forest
21%
Mouse
21%
Cyclin-Dependent Kinase 9
21%
DNA Gyrase
21%
Glycated Hemoglobin
21%
Poly ADP Ribose Polymerase
21%
Synapsin I
21%
Methyldopa
21%
Amyloid
21%
Microbial Metabolism
21%
Leporidae
21%
Glucocorticoid
18%
Antidiabetic Activity
18%
Promoter Region
15%
Cancer Cell
15%
Mucor
15%
Signal Transduction
14%
Stevioside
12%
Luciferase
11%
Aspergillus Niger
9%
TLR2
9%
P53
9%
Ferulic Acid
8%
Carbidopa
8%
Single Drug Dose
8%
DNA Virus
8%
Steroidogenic Factor 1
8%
Exocytosis
7%
Medicine and Dentistry
Breast Cancer
57%
Cyclooxygenase 2 Inhibitor
43%
Cancer Therapy
30%
Cyclooxygenase 2
28%
Benzenesulfonamide Derivative
28%
Adverse Event
25%
Antidiabetic Agent
24%
Biological Therapy
21%
Stilbene
21%
Hepatitis B Virus
21%
Network Meta-Analysis
21%
Antivirus Agent
21%
Chronic Urticaria
21%
Breast Cancer Survival
21%
Quercetin
21%
Diabetes
21%
Glycoside
21%
PARP Inhibitor
21%
Pancreas Cancer
21%
Protein Binding
21%
Synapsin I
21%
Amyloid
21%
Biological Activity
21%
DNA Topoisomerase (ATP Hydrolysing)
21%
Anticarcinogen
21%
Activator Protein 1
21%
Luteolin
21%
Cytotoxicity
21%
Immunosuppressant
21%
Lignan
21%
Lactone
21%
Omalizumab
17%
Incubation
14%
Celecoxib
14%
IC50
14%
Structure-Activity Relationship
14%
Dermatology Life Quality Index
12%
Neoplasm
12%
Clinical Research
12%
Drug Therapy
11%
Antidiabetic Activity
10%
Fibril Formation
10%
Fibril Assembly
10%
Malignant Neoplasm
10%
In Vitro
10%
Chlorogenic Acid
10%
Tumor Cell Line
10%
Glucuronide
10%
Cell Line
10%
Sesquiterpene Lactone
10%
